Virus vaccines
1 / 11

Virus vaccines - PowerPoint PPT Presentation

  • Uploaded on

LECTURE 18:. Virus vaccines. Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology. Waqas Nasir Chaudhry. Live recombinant virus vaccines.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' Virus vaccines' - bree

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Virus vaccines


Virus vaccines



3 Credit hours

NUST Centre of Virology & Immunology


Live recombinant virus vaccines
Live recombinant virusvaccines

  • A recombinant vaccinia virus engineered to contain the gene for the rabies virus G protein has been used to vaccinate wild mammals against rabies

Live recombinant virus vaccines

Virus like particles
Virus like particles

  • Virus-like particles are structures assembled from virus proteins

  • The particles resemble virions, but they are devoid of any nucleic acid

  • Therefore be deemed safer than vaccines containing attenuated or inactivated virions

  • Hepatitis B virus (HBV) vaccine is produced in recombinant yeast cells that have the gene for the HBsAginserted into the genome

  • The cells are grown in bulk and then broken to release the virus protein.

  • After purification the HBsAg molecules receive a chemical treatment that causes them to aggregate into spherical structures similar to the non-infectious of HBV

  • The major capsid protein of papillomaviruses can self assemble into virus-like particles that bear the epitopes required for generating neutralizing antibodies

Synthetic peptide vaccines
Synthetic peptide vaccines

  • Each protein antigen has one or more epitopes

  • These short amino acid sequences can be synthesized in a machine and it was suggested that the resulting peptides might be used as vaccines

  • Compared with traditional vaccines it would be easier to ensure the absence of contaminants such as viruses and proteins

  • A lot of work has been done to try to develop peptide vaccines against foot and mouth disease virus

  • In this virus there is an important epitope within the virion protein VP1

  • Synthetic peptides of this sequence induced reasonable levels of neutralizing and protective antibodies in laboratory animals

  • but when vaccine trials were done in farm animals the results were disappointing

Dna vaccines
DNA vaccines

  • The most revolutionary approach to vaccination is the introduction into the vaccinee of DNA encoding an antigen, with the aim of inducing cells of the vaccineeto synthesize the antigen

  • One advantage of this approach is that there is a steady supply of new antigen to stimulate the immune system

  • Because the antigen (a virus protein in this case) is produced within the cells of the vaccinee, it is likely to stimulate efficient T-cell-mediated responses

Production of a DNA vaccine. The virus protein gene is inserted into a plasmid, which is then cloned in bacteria. The plasmid is extracted from the bacterial cells, purified and incorporated into a vaccine

Storage and transport of vaccines
Storage and transport inserted into a plasmid, which is then cloned of vaccines

  • Once a vaccine has been manufactured there is a need to preserve its efficacy until it is used

  • For live vaccines this means preserving virus infectivity

  • For vaccines containing inactivated virions, subunits and virus-like particles it means preserving immunogenicity

  • Most vaccines are stored and transported at low temperatures this minimizes losses of infectivity and immunogenicity

  • Substances that reduce the rate of infectivity loss are included in some vaccines, an example being magnesium chloride in live polio vaccines

Low temperature storage of inserted into a plasmid, which is then cloned virus vaccines